12/2
03:41 pm
eldn
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/1
07:13 am
eldn
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
12/1
07:00 am
eldn
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
Medium
Report
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
11/18
04:05 pm
eldn
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
Medium
Report
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
11/18
09:14 am
eldn
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
11/17
01:19 pm
eldn
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
Low
Report
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
11/14
05:58 pm
eldn
Eledon Pharmaceuticals GAAP EPS of -$0.21 [Seeking Alpha]
High
Report
Eledon Pharmaceuticals GAAP EPS of -$0.21 [Seeking Alpha]
11/14
05:26 pm
eldn
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results [Yahoo! Finance]
11/14
05:00 pm
eldn
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
Medium
Report
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
11/12
07:56 am
eldn
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Low
Report
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
11/11
05:33 pm
eldn
Eledon Pharmaceuticals launches proposed public offering of common stock and pre-funded warrants [Seeking Alpha]
Medium
Report
Eledon Pharmaceuticals launches proposed public offering of common stock and pre-funded warrants [Seeking Alpha]
11/11
05:26 pm
eldn
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
11/9
10:41 pm
eldn
Assessing Eledon Pharmaceuticals (ELDN) Valuation After Phase 2 Kidney Transplant Trial Results and Phase 3 Prospects [Yahoo! Finance]
Medium
Report
Assessing Eledon Pharmaceuticals (ELDN) Valuation After Phase 2 Kidney Transplant Trial Results and Phase 3 Prospects [Yahoo! Finance]
11/6
07:40 pm
eldn
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology's Kidney Week 2025 Annual Meeting [Yahoo! Finance]
High
Report
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology's Kidney Week 2025 Annual Meeting [Yahoo! Finance]
11/6
06:30 pm
eldn
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
High
Report
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
11/5
07:00 am
eldn
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
Medium
Report
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
10/24
12:21 pm
eldn
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
10/17
07:00 am
eldn
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
High
Report
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
10/9
08:33 am
eldn
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) is largely controlled by institutional shareholders who own 51% of the company [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) is largely controlled by institutional shareholders who own 51% of the company [Yahoo! Finance]
10/8
12:20 pm
eldn
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
9/24
05:23 pm
eldn
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association [Yahoo! Finance]
9/24
04:05 pm
eldn
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
Low
Report
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
9/23
10:52 am
eldn
2 ‘Strong Buy' Stocks That Wall Street Believes Can Soar 360% to 780% [Yahoo! Finance]
Medium
Report
2 ‘Strong Buy' Stocks That Wall Street Believes Can Soar 360% to 780% [Yahoo! Finance]